Narek Shaverdian, MD

Memorial Sloan Kettering radiation oncologist Narek Shaverdian
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a radiation oncologist who specializes in caring for people with lung cancer, brain and other nervous system tumors, prostate cancer, and bladder cancer. I see patients at MSK Commack on Long Island.

I was drawn to being a cancer doctor and researcher because, as with so many families, mine too has been impacted by this disease. I strive to provide the same personalized care that I would hope someone in my own family would receive.

When I first meet patients, I help them understand the role radiation therapy can play in their specific treatment plan. Often patients may have new questions or challenges after we meet, so I want my patients to know that I strive to be completely accessible. I am committed to working through all the steps with them to ensure that they have the best treatment experience and best outcome. It is a great privilege to get to know my patients and their families and work to provide cutting-edge, personalized care.

There have been great advances in radiation oncology. These enable us to control and defeat cancer with minimal side effects. At Memorial Sloan Kettering, we take advantage of the most sophisticated image guidance technology to deliver radiation with great precision. We have developed ways to treat some people with fewer sessions by using higher, tightly focused doses. We are also investigating ways to combine radiation with certain drugs to get even better results.  

In addition to my clinical practice, I conduct research on the interaction between radiation therapy and a person’s own immune system. This is a growing area of research in which we are looking for ways to improve the effectiveness of radiation therapy by giving immunotherapy drugs. I am also interested in finding ways we can better understand the concerns and perspectives of our patients as they undergo treatment.

I also want patients to know that the care I provide is complemented by a large team of experts in oncology, surgery, radiology, and pathology, all who work closely with each other. I hope my patients always leave my office feeling informed, comfortable, and confident in their treatment plan.

  • Clinical Expertise: Lung Cancer; Brain Cancer and Other Central Nervous System Tumors; Prostate Cancer; Image-Guided Radiation Therapy (IGRT); Intensity-Modulated Radiation Therapy (IMRT); Streotactic Radiosurgery (SRS); Stereotactic Body Radiation Therapy (SBRT); Stereotactic Ablative Radiotherapy (SABR)
  • Awards and Honors: Radiological Society of North America (RSNA) Roentgen Research Award (2018); American Society for Radiation Oncology (ASTRO) Basic/Translational Science Abstract Award (2017); American Society for Clinical Oncology (ASCO) Merit Award (2017); American Medical Association (AMA) Foundation Seed Grant (2017); American College of Radiation Oncology (ACRO) Grant (2015); Alpha Omega Alpha Honor Medical Society (2013)
  • Languages Spoken: English
  • Education: MD, University of Wisconsin
  • Residencies: Preliminary Medicine - University of Washington; Radiation Oncology - University of California Los Angeles


Shaverdian N, Wang X, Hegde JV, Aledia C, Weidhaas JB, Steinberg ML, McCloskey SA. The patient’s perspective on breast radiation therapy: Initial fears and expectations versus reality. Cancer. 2018 Apr 15;124(8):1673-1681

Shaverdian N, Lisberg AE, Bornazyan K, Veruttipong D, Goldman JW, Formenti SC, Garon EB, Lee P. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Lancet Oncology. 2017 Jul;18(7):895-903.

Shaverdian N, Veruttipong D, Wang PC, Kishan AU, Demanes DJ, McCloskey S, Kupelian P, Steinberg ML, King CR. Exploring value from the patient’s perspective between modern radiation therapy modalities for localized prostate cancer. International Journal of Radiation Oncology, Biology, and Physics. 2017 Mar 1;97(3):516-525.

Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Pretreatment anemia portends poor survival and nonlocal disease progression in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Journal of Thoracic Oncology. 2016 Aug;11(8):1319-25.

Shaverdian N, Wang PC, Steinberg M, Lee P. The patient’s perspective on stereotactic body radiation therapy vs. surgery for the treatment of early stage non-small cell lung cancer. Lung Cancer. 2015 Nov;90(2):230-3.

Visit PubMed for a full listing of Narek Shaverdian’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.